Effect of TTP488 in patients with mild to moderate Alzheimer’s disease

Overview of attention for article published in BMC Neurology, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs: 2 blogs

twitter: 4 X users

Citations

dimensions_citation: 101 Dimensions

Readers on

mendeley: 109 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 2 posts from 2 blogs.

Azeliragon

New Drug Approvals, 10 Oct 2019

Azeliragon C32H38ClN3O2, 532.1 g/mol CAS 603148-36-3…

Another Alzheimer's IPO

In the Pipeline, 30 Jul 2015

I've been saying a lot of unkind things about Axovant, the insta-company that's taking a discarded GSK Alzheimer's candidate…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.